In the face of a gene editing breakthrough this week, Insoo Hyun, an associate professor in the Department of Bioethics at Case Western Reserve University talked about CRISPR vs. preimplantation genetic diagnosis to help couples select healthy embryos.
The Cleveland school currently is evaluating Microsoft's HoloLens "mixed reality" technology for medical education.
The hope is that this NIH-funded data provenance project will help standardize and reconcile inconsistencies so clinicians have better data to bring to the bedside and run through clinical decision support systems.
A new set of therapeutics for inflammatory and vascular disorders is being developed in Cleveland – based on research from a trio of lauded cardiovascular researchers. Sujana Biotech just raised $800,000 of a potential $5 million round, according to a regulatory filing. According to BioMotiv, the scientific backing for the new therapeutics come from Daniel Simon, chief […]
A new prosthetic limb can restore sensation for people who have lost a limb and even relieve the phantom pains they feel, LiveScience reports. Developed by researchers at Cleveland’s Case Western Reserve and the government’s APT Center, the prosthesis stimulates the nerves in a patient’s upper arm, allowing them to once again experience the sense of touch. […]
Academic researchers, by nature, pursue scientifically interesting discoveries that could have a long-term impact. Meanwhile, investors and companies are interested in technologies that fill a very clear and immediate need in a market. That difference in perspective is one thing that makes translating discoveries at academic institutions into viable products so challenging, as I learned […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
How big is the potential of big data in healthcare? So enormous that three Ohio medical powerhouses have teamed up, set aside some $21.5 million and called on a noted computational geneticist to lead a venture that will bolster their ability to find meaning from it. Case Western Reserve University is spearheading a new Institute […]
When Brian Grimberg and a team at Case Western Reserve University began working on their Rapid Assessment of Malaria (RAM) device nearly four years ago, it was the size of a kitchen table. Today, the functional prototype is a handheld device that the team thinks can diagnose the tropical disease more quickly, simply and affordably. […]
Even before the Supreme Court ruled on Myriad Genetics yesterday, there was talk in the biotech industry that a decision against the company’s patents would spell bad news for innovation. Trade group BIO is among those expressing concern post-ruling about how young biotechs who have built their business models on DNA patents will fare. Others […]
In the world of Alzheimer’s disease drugs, the past year has been marked by disappointing Phase 3 clinical trial results for a handful of much-anticipated antibody drugs. But the failure of those drugs, designed to clear toxic beta amyloid plaques that accumulate in the brain, isn’t discouraging to Cleveland startup ReXceptor Inc., which has just […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Google Flu Trends project is a great example of not only the potential use for big data at a public health level, but also some of the challenges that come with it. When armed with de-identified health data from multiple sources – rather than the smaller pool of patients an institution sees within its […]
Market research has suggested that neuromodulation devices make up the fastest-growing segment of the medical device sector, forecasting some $7 billion in sales within five years. Although medical device giants Medtronic, St. Jude Medical and Boston Scientific dominate the market, there are a number of young companies working on nerve stimulation devices to treat pain […]
Thanks to a new three-year, $1 million grant, a group of researchers at Case Western Reserve University are continuing to develop and test a form of glucose-responsive insulin that may someday be able to reduce the risk of dangerous hypoglycemic episodes in people with type 1 diabetes. The insulin is being developed in the lab […]
It took awhile but the White House decided to take back the label Obamacare and put a positive spin on it. The administration’s next marketing campaign should be around PCORI. It doesn’t roll off the tongue, but the Patient Centered Outcomes Research Institute is the carrot to the individual mandate stick. The Institute is working […]
Sensors and medicine just go together. Already we’ve seen sensors embedded into medical technology to help detect breast cancer, potential concussions and early signs of foot ulcers, just to name a few. Now a Cleveland-area startup is applying pressure sensors to breathing and feeding tubes to prevent and detect intubation complications. “Our goal is really […]
